Penumbra Inc (PEN) support and resistance · P/E 237, rev $1.19B
Penumbra Inc (PEN) is a medical devices company listed on US.
This page maps Penumbra Inc (PEN) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported PEN revenue for 2024-12-31 was $1.19B. Net income was $14.0M. Revenue was up 319.6% from 2023-12-31 to 2024-12-31. PEN currently screens at market cap $9.93B and trailing P/E 237.4.
PEN currently screens at market cap $9.93B and trailing P/E 237.4. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new PEN 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the PEN quote page for the session range and the stock page for the full model.
Not investment advice.